The ROE (Return on Equity) of Zynerba Pharmaceuticals Inc (ZYNE) is -75.79%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2022-12-31 | -75.79% |
| 2021-12-31 | -52.61% |
| 2020-12-31 | -85.37% |
| 2019-12-31 | -43.57% |
| 2018-12-31 | -69.29% |
| 2017-12-31 | -52.52% |
| 2016-12-31 | -79.05% |
| 2015-12-31 | -31.60% |
| 2014-12-31 | -66.94% |
| 2013-12-31 | 53.33% |